Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Development and Use of an Endpoint Titration Assay To Characterize Mumps IgG Avidity following Measles, Mumps, and Rubella Vaccination and Wild-Type Mumps Infection.

Mercader S, McGrew M, Sowers SB, Williams NJ, Bellini WJ, Hickman CJ.

mSphere. 2018 Sep 12;3(5). pii: e00320-18. doi: 10.1128/mSphere.00320-18.

2.

Measles, mumps, and rubella antibody patterns of persistence and rate of decline following the second dose of the MMR vaccine.

Seagle EE, Bednarczyk RA, Hill T, Fiebelkorn AP, Hickman CJ, Icenogle JP, Belongia EA, McLean HQ.

Vaccine. 2018 Feb 1;36(6):818-826. doi: 10.1016/j.vaccine.2017.12.075. Epub 2018 Jan 6.

PMID:
29317117
3.

Mumps Virus Nucleoprotein and Hemagglutinin-Specific Antibody Response Following a Third Dose of Measles Mumps Rubella Vaccine.

Latner DR, Parker Fiebelkorn A, McGrew M, Williams NJ, Coleman LA, McLean HQ, Rubin S, Hickman CJ.

Open Forum Infect Dis. 2017 Dec 8;4(4):ofx263. doi: 10.1093/ofid/ofx263. eCollection 2017 Fall.

4.

High Concentrations of Measles Neutralizing Antibodies and High-Avidity Measles IgG Accurately Identify Measles Reinfection Cases.

Sowers SB, Rota JS, Hickman CJ, Mercader S, Redd S, McNall RJ, Williams N, McGrew M, Walls ML, Rota PA, Bellini WJ.

Clin Vaccine Immunol. 2016 Aug 5;23(8):707-16. doi: 10.1128/CVI.00268-16. Print 2016 Aug.

5.

Measles Outbreak Associated With Low Vaccine Effectiveness Among Adults in Pohnpei State, Federated States of Micronesia, 2014.

Hales CM, Johnson E, Helgenberger L, Papania MJ, Larzelere M, Gopalani SV, Lebo E, Wallace G, Moturi E, Hickman CJ, Rota PA, Alexander HS, Marin M.

Open Forum Infect Dis. 2016 Mar 24;3(2):ofw064. doi: 10.1093/ofid/ofw064. eCollection 2016 Mar.

6.

Measles Virus Neutralizing Antibody Response, Cell-Mediated Immunity, and Immunoglobulin G Antibody Avidity Before and After Receipt of a Third Dose of Measles, Mumps, and Rubella Vaccine in Young Adults.

Fiebelkorn AP, Coleman LA, Belongia EA, Freeman SK, York D, Bi D, Kulkarni A, Audet S, Mercader S, McGrew M, Hickman CJ, Bellini WJ, Shivakoti R, Griffin DE, Beeler J.

J Infect Dis. 2016 Apr 1;213(7):1115-23. doi: 10.1093/infdis/jiv555. Epub 2015 Nov 23.

7.

Remembering mumps.

Latner DR, Hickman CJ.

PLoS Pathog. 2015 May 7;11(5):e1004791. doi: 10.1371/journal.ppat.1004791. eCollection 2015 May. Review. No abstract available.

8.

Susceptibility to Measles Among Perinatally HIV-Infected Adolescents and Young Adults.

Morris LE, Posada R, Hickman CJ, Latner DR, Singh TA, Rautenberg A, Jao J, Bellini WJ, Sperling R.

J Pediatric Infect Dis Soc. 2015 Mar;4(1):63-6. doi: 10.1093/jpids/pit054. Epub 2013 Sep 24.

9.

Outbreak of measles among persons with prior evidence of immunity, New York City, 2011.

Rosen JB, Rota JS, Hickman CJ, Sowers SB, Mercader S, Rota PA, Bellini WJ, Huang AJ, Doll MK, Zucker JR, Zimmerman CM.

Clin Infect Dis. 2014 May;58(9):1205-10. doi: 10.1093/cid/ciu105. Epub 2014 Feb 27.

PMID:
24585562
10.

Estimates of mumps seroprevalence may be influenced by antibody specificity and serologic method.

Latner DR, McGrew M, Williams NJ, Sowers SB, Bellini WJ, Hickman CJ.

Clin Vaccine Immunol. 2014 Mar;21(3):286-97. doi: 10.1128/CVI.00621-13. Epub 2013 Dec 26.

11.

Viruses detected among sporadic cases of parotitis, United States, 2009-2011.

Barskey AE, Juieng P, Whitaker BL, Erdman DD, Oberste MS, Chern SW, Schmid DS, Radford KW, McNall RJ, Rota PA, Hickman CJ, Bellini WJ, Wallace GS.

J Infect Dis. 2013 Dec 15;208(12):1979-86. doi: 10.1093/infdis/jit408. Epub 2013 Aug 9.

PMID:
23935203
12.

Comparison of the sensitivity of laboratory diagnostic methods from a well-characterized outbreak of mumps in New York city in 2009.

Rota JS, Rosen JB, Doll MK, McNall RJ, McGrew M, Williams N, Lopareva EN, Barskey AE, Punsalang A Jr, Rota PA, Oleszko WR, Hickman CJ, Zimmerman CM, Bellini WJ.

Clin Vaccine Immunol. 2013 Mar;20(3):391-6. doi: 10.1128/CVI.00660-12. Epub 2013 Jan 16.

13.

Mumps outbreak in Orthodox Jewish communities in the United States.

Barskey AE, Schulte C, Rosen JB, Handschur EF, Rausch-Phung E, Doll MK, Cummings KP, Alleyne EO, High P, Lawler J, Apostolou A, Blog D, Zimmerman CM, Montana B, Harpaz R, Hickman CJ, Rota PA, Rota JS, Bellini WJ, Gallagher KM.

N Engl J Med. 2012 Nov 1;367(18):1704-13. doi: 10.1056/NEJMoa1202865.

14.

Mumps antibody levels among students before a mumps outbreak: in search of a correlate of immunity.

Cortese MM, Barskey AE, Tegtmeier GE, Zhang C, Ngo L, Kyaw MH, Baughman AL, Menitove JE, Hickman CJ, Bellini WJ, Dayan GH, Hansen GR, Rubin S.

J Infect Dis. 2011 Nov;204(9):1413-22. doi: 10.1093/infdis/jir526. Epub 2011 Sep 20.

PMID:
21933874
15.

Two case studies of modified measles in vaccinated physicians exposed to primary measles cases: high risk of infection but low risk of transmission.

Rota JS, Hickman CJ, Sowers SB, Rota PA, Mercader S, Bellini WJ.

J Infect Dis. 2011 Jul;204 Suppl 1:S559-63. doi: 10.1093/infdis/jir098.

PMID:
21666213
16.

Laboratory characterization of measles virus infection in previously vaccinated and unvaccinated individuals.

Hickman CJ, Hyde TB, Sowers SB, Mercader S, McGrew M, Williams NJ, Beeler JA, Audet S, Kiehl B, Nandy R, Tamin A, Bellini WJ.

J Infect Dis. 2011 Jul;204 Suppl 1:S549-58. doi: 10.1093/infdis/jir106.

PMID:
21666212
17.

Enzyme-linked immunospot assay detection of mumps-specific antibody-secreting B cells as an alternative method of laboratory diagnosis.

Latner DR, McGrew M, Williams N, Lowe L, Werman R, Warnock E, Gallagher K, Doyle P, Smole S, Lett S, Cocoros N, DeMaria A, Konomi R, Brown CJ, Rota PA, Bellini WJ, Hickman CJ.

Clin Vaccine Immunol. 2011 Jan;18(1):35-42. doi: 10.1128/CVI.00284-10. Epub 2010 Nov 3.

18.

Seroprevalence of antibody to mumps virus in the US population, 1999-2004.

Kutty PK, Kruszon-Moran DM, Dayan GH, Alexander JP, Williams NJ, Garcia PE, Hickman CJ, McQuillan GM, Bellini WJ.

J Infect Dis. 2010 Sep 1;202(5):667-74. doi: 10.1086/655394.

PMID:
20662720
19.

Laboratory confirmation of measles in elimination settings: experience from the Republic of the Marshall Islands, 2003.

Hyde TB, Nandy R, Hickman CJ, Langidrik JR, Strebel PM, Papania MJ, Seward JF, Bellini WJ.

Bull World Health Organ. 2009 Feb;87(2):93-8.

20.

SARS-coronavirus replication in human peripheral monocytes/macrophages.

Yilla M, Harcourt BH, Hickman CJ, McGrew M, Tamin A, Goldsmith CS, Bellini WJ, Anderson LJ.

Virus Res. 2005 Jan;107(1):93-101.

PMID:
15567038
21.

Induction of cytokine mRNA in peripheral blood mononuclear cells of infants after the first dose of measles vaccine.

Li H, Hickman CJ, Helfand RF, Keyserling H, Anderson LJ, Bellini WJ.

Vaccine. 2001 Sep 14;19(32):4896-900.

PMID:
11535343
22.
23.

Murine T-cell response to native and recombinant protein antigens of Rickettsia tsutsugamushi.

Hickman CJ, Stover CK, Joseph SW, Oaks EV.

Infect Immun. 1993 May;61(5):1674-81.

24.

Mycobacterium tuberculosis expresses two chaperonin-60 homologs.

Kong TH, Coates AR, Butcher PD, Hickman CJ, Shinnick TM.

Proc Natl Acad Sci U S A. 1993 Apr 1;90(7):2608-12.

25.

Molecular cloning and sequence analysis of a Rickettsia tsutsugamushi 22 kDa antigen containing B- and T-cell epitopes.

Hickman CJ, Stover CK, Joseph SW, Oaks EV.

Microb Pathog. 1991 Jul;11(1):19-31.

PMID:
1724548
26.

Regulation of human cytotoxic T lymphocyte development by IL-7.

Hickman CJ, Crim JA, Mostowski HS, Siegel JP.

J Immunol. 1990 Oct 15;145(8):2415-20.

PMID:
2145359
27.

A new method of testing the pathogenicity of Phytophthora fragariae.

HICKMAN CJ, GOODE PM.

Nature. 1953 Aug 1;172(4370):211-2. No abstract available.

PMID:
13087166

Supplemental Content

Loading ...
Support Center